KU Leuven
Leuven, Vlaams Brabant, 3000, Belgium
Location status: Recruiting
Location contact
Christophe Matthys, Professor
CONTACT
Christophe Matthys, Professor
PRINCIPAL_INVESTIGATOR
Joanna M Eksteen, MSc
CONTACT
NCT Number: NCT06485960
A new dietary assessment method was developed based on the Experience Sampling Methodology. In order to use this newly developed Experience Sampling Dietary Assessment Method (ESDAM) in research and clinical practice as a valid and reliable method to measure dietary intake the ESDAM needs to be validated against objective biomarkers and reference methods.
Interested in participating?
Request Info18 year–65 year
All sexes
Observational
Leuven, Vlaams Brabant, 3000, Belgium
Location status: Recruiting
Christophe Matthys, Professor
CONTACT
Christophe Matthys, Professor
PRINCIPAL_INVESTIGATOR
Joanna M Eksteen, MSc
CONTACT
The purpose of this research project is to advance nutritional research by delivering an improved, accurate, feasible and reliable method to assess dietary intake. Our newly developed approach to collate dietary intake based on experience sampling methodology (ESM) will serve this purpose.
Therefore, this research aims to validate the newly developed Experience Sampling Dietary Assessment Method (ESDAM) by assessing construct validity compared to blood and urine biomarkers representing dietary intake. This will eventually result in the newly developed dietary assessment method being evidence-based and validated and, thus, ready-to-use as a reliable method for research and clinical practice.
Therefore, the ESDAM will be validated against repeated 24-hour dietary recalls, the doubly-labelled water method, urinary nitrogen and blood biomarkers. The study has a duration of four weeks. The first two weeks will be used to collect baseline data including socio-demographic, biometric data and three 24-hour recalls to assess dietary intake. During the last two weeks the Experience Sampling Dietary Assessment Method will be evaluated against urine biomarkers (Doubly-labeled water and urinary nitrogen), blood biomarkers (erythrocyte membrane fatty acid composition, beta-carotenoids, polyphenols) together with continuous glucose monitoring and two wrist-worn motion sensor devices to track eating- related movements.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 2 weeks
Daily dietary energy intake estimated by the Experience Sampling Dietary Assessment Method (ESDAM) compared to the Doubly-labeled Water Method
Time frame: 2 weeks
Daily dietary protein intake estimated by the Experience Sampling Dietary Assessment Method (ESDAM) compared to urinary nitrogen
Time frame: 2 weeks
Daily energy expenditure (kcal/day) measured by the doubly-labeled water method
Time frame: 2 weeks
Daily dietary protein intake based on urinary nitrogen analysis
Time frame: 2 weeks
Daily nutrient and food group consumption estimated by the Experience Sampling Dietary Assessment Method ESDAM
Time frame: 2 weeks
Energy, nutrient and food group consumption measured by the 24-hour dietary recalls
Time frame: 4 weeks
Serum Beta-carotenoids as biomarker of fruit and vegetable consumption
Time frame: 4 weeks
Erythrocyte membrane fatty acid composition as biomarker of fatty acid consumption
Time frame: 4 weeks
Plasma polyphenol concentration as an indication of dietary polyohenol intake
Time frame: 2 weeks
Timing of glucose peaks registered by Continuous Glucose Monitoring
Time frame: 2 weeks
Timing of eating-related motion monitored by wrist-worn motion sensors
Contact information is provided by the study sponsor or research team.
KU Leuven
Other
Validation of the Experience Sampling Dietary Assessment Method (ESDAM)
Acronym: YONAS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07504913
Digestive System Diseases, Digestive System Neoplasms
Badalona, Barcelona, Spain
View Trial DetailsNCT06854874
Validation Study
Florence, Italy
View Trial DetailsNCT07395700
Behavior, Behavior, Addictive
Ajijic, Jalisco, Mexico
View Trial DetailsNCT06260800
Validation Study
Soria, Spain
View Trial Details